Beximco Pharmaceuticals Limited
BXP.L · LSE
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £1,830 | £1,681 | £0 | £1,365 |
| Dep. & Amort. | £0 | £0 | £0 | -£985 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£789 | £0 | £809 | £743 |
| Other Non-Cash | -£3 | £17 | £957 | £1,008 |
| Operating Cash Flow | £1,038 | £1,697 | £1,766 | £2,131 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1,216 | -£311 | -£621 | -£389 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£342 | -£265 | -£34 | £45 |
| Investing Cash Flow | -£1,558 | -£576 | -£655 | -£344 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £1,324 | -£1,122 | -£1,412 | -£196 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | -£0 | -£1 | -£18 | -£1,567 |
| Other Fin. Act. | £0 | £0 | £0 | £41 |
| Financing Cash Flow | £1,324 | -£1,124 | -£1,430 | -£1,722 |
| Forex Effect | -£8 | £8 | £12 | £0 |
| Net Chg. in Cash | £796 | £5 | -£306 | £65 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £859 | £854 | £1,160 | £1,096 |
| End Cash | £1,655 | £859 | £854 | £1,160 |
| Free Cash Flow | -£280 | £1,387 | £1,145 | £1,715 |